This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (96)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Prostate Cancer  • Alert me on articles by topic  Social Bookmarking   What's this?

Does Practice Reflect the Evidence?

Brenda E. Sirovich, MD, MS; Lisa M. Schwartz, MD, MS; Steven Woloshin, MD, MS

JAMA. 2003;289:1414-1420.

Context  The debate about the efficacy of prostate-specific antigen (PSA) screening for prostate cancer has received substantial attention in the medical literature and the media, but the extent to which men are actually screened is unknown. If practice were evidence-based, PSA screening would be less common among men than colorectal cancer screening, a preventive service of broad acceptance and proven efficacy.

Objective  To compare the prevalences of PSA and colorectal cancer screening among US men.

Design, Setting, and Population  The 2001 Behavioral Risk Factor Surveillance System, an annual population-based telephone survey of US adults conducted by the Centers for Disease Control and Prevention, was used to gather data on a representative sample of men aged 40 years or older from all 50 states and the District of Columbia (n = 49 315).

Main Outcome Measures  Proportions of men ever screened and up to date on screening for prostate cancer (with PSA testing) and colorectal cancer (with fecal occult blood testing, flexible sigmoidoscopy, or colonoscopy).

Results  Overall, men are more likely to report having ever been screened for prostate cancer than for colorectal cancer; 75% of those aged 50 years or older have had a PSA test vs 63% for any colorectal cancer test (risk ratio [RR], 1.20; 95% confidence interval [CI], 1.18-1.21). Up-to-date PSA screening is also more common than colorectal cancer screening for men of all ages. Among men aged 50 to 69 years (those for whom there is the greatest consensus in favor of screening), 54% reported an up-to-date PSA screen, while 45% reported up-to-date testing for colorectal cancer (RR, 1.19; 95% CI, 1.16-1.21). In state-level analyses of this age group, men were significantly more likely to be up to date on prostate cancer screening compared with colorectal cancer screening in 27 states, while up-to-date colorectal cancer screening was more common in only 1 state.

Conclusion  Among men in the United States, prostate cancer screening is more common than colorectal cancer screening. Physicians should ensure that men who choose to be screened for cancer are aware of the known mortality benefit of colorectal cancer screening and the uncertain benefits of screening for prostate cancer.

Author Affiliations: VA Outcomes Group, White River Junction, Vt (Drs Sirovich, Schwartz, and Woloshin), and Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, NH (Drs Schwartz and Woloshin).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prostate-Specific Antigen Testing among the Elderly in Community-Based Family Medicine Practices
Hudson et al.
J Am Board Fam Med 2009;22:257-265.
ABSTRACT | FULL TEXT  

Impact of Age and Comorbidity on Colorectal Cancer Screening Among Older Veterans
Walter et al.
ANN INTERN MED 2009;150:465-473.
ABSTRACT | FULL TEXT  

The Influence of Statin Medications on Prostate-specific Antigen Levels
Hamilton et al.
JNCI J Natl Cancer Inst 2008;100:1511-1518.
ABSTRACT | FULL TEXT  

Effect of Guidelines on Primary Care Physician Use of PSA Screening: Results from the Community Tracking Study Physician Survey
Guerra et al.
Med Decis Making 2008;28:681-689.
ABSTRACT  

Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention
Lucia et al.
Cancer Prevention Research 2008;1:167-173.
ABSTRACT | FULL TEXT  

Reactions of potential jurors to a hypothetical malpractice suit alleging failure to perform a prostate-specific antigen test.
Barry et al.
J Law Med Ethics 2008;36:396-402.
 

Prevalence of Delayed Clinician Response to Elevated Prostate-Specific Antigen Values
Nepple et al.
Mayo Clin Proc. 2008;83:439-445.
ABSTRACT | FULL TEXT  

Use of the Prostate-Specific Antigen Test among U.S. Men: Findings from the 2005 National Health Interview Survey
Ross et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:636-644.
ABSTRACT | FULL TEXT  

Transforming Clinical Practice Guidelines Into Legislative Mandates: Proceed With Abundant Caution
Jacobson
JAMA 2008;299:208-210.
FULL TEXT  

Trends in Prostate-Specific Antigen Testing From 1995 Through 2004
Farwell et al.
Arch Intern Med 2007;167:2497-2502.
ABSTRACT | FULL TEXT  

Obesity-Related Plasma Hemodilution and PSA Concentration Among Men With Prostate Cancer
Banez et al.
JAMA 2007;298:2275-2280.
ABSTRACT | FULL TEXT  

Preventive Health Examinations and Preventive Gynecological Examinations in the United States
Mehrotra et al.
Arch Intern Med 2007;167:1876-1883.
ABSTRACT | FULL TEXT  

Point: Genetic Risk Feedback for Common Disease Time to Test the Waters
McBride and Brody
Cancer Epidemiol. Biomarkers Prev. 2007;16:1724-1726.
FULL TEXT  

Assessing Individual Risk for Prostate Cancer
Nam et al.
JCO 2007;25:3582-3588.
ABSTRACT | FULL TEXT  

Commentary: The ubiquity of prostate cancer: echoes of the past, implications for the present
Thompson et al.
Int J Epidemiol 2007;0:dym056v1-3.
FULL TEXT  

Delivery of Cancer Screening: How Important Is the Preventive Health Examination?
Fenton et al.
Arch Intern Med 2007;167:580-585.
ABSTRACT | FULL TEXT  

Validity of Self-Reports of Return for Routine Repeat Screening in an Ovarian Cancer Screening Program
Lykins et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:490-493.
ABSTRACT | FULL TEXT  

Relation Between Medicare Screening Reimbursement and Stage at Diagnosis for Older Patients With Colon Cancer
Gross et al.
JAMA 2006;296:2815-2822.
ABSTRACT | FULL TEXT  

PSA Screening Among Elderly Men With Limited Life Expectancies.
Walter et al.
JAMA 2006;296:2336-2342.
ABSTRACT | FULL TEXT  

Improving Men's Health: Evidence and Opportunity.
Fontanarosa and Cole
JAMA 2006;296:2373-2375.
FULL TEXT  

Colon cancer screening: the good, the bad, and the ugly.
Roy et al.
Arch Intern Med 2006;166:2177-2179.
FULL TEXT  

The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening.
Gross et al.
ANN INTERN MED 2006;145:646-653.
ABSTRACT | FULL TEXT  

Risk of Cardiovascular Mortality in Prostate Cancer Patients in the Rotterdam Randomized Screening Trial
Otto et al.
JCO 2006;24:4184-4189.
ABSTRACT | FULL TEXT  

Who Owns Your Body? A Patient's Perspective on Washington University v. Catalona
Andrews
J Law Med Ethics 2006;34:398-407.
 

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
Stephenson et al.
JNCI J Natl Cancer Inst 2006;98:715-717.
ABSTRACT | FULL TEXT  

Disease and disadvantage in the United States and in England.
Banks et al.
JAMA 2006;295:2037-2045.
ABSTRACT | FULL TEXT  

Total and Percent Free Prostate-Specific Antigen Levels among U.S. Men, 2001-2002
Saraiya et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:2178-2182.
ABSTRACT | FULL TEXT  

Operating Characteristics of Prostate-Specific Antigen in Men With an Initial PSA Level of 3.0 ng/mL or Lower
Thompson et al.
JAMA 2005;294:66-70.
ABSTRACT | FULL TEXT  

Does 'peer coaching' increase GP capacity to promote informed decision making about PSA screening? A cluster randomised trial
Gattellari et al.
Fam Pract 2005;22:253-265.
ABSTRACT | FULL TEXT  

Making Policy When The Evidence Is In Dispute
Atkins et al.
Health Aff (Millwood) 2005;24:102-113.
ABSTRACT | FULL TEXT  

Pretreatment Evaluation of Prostate Cancer: Role of MR Imaging and 1H MR Spectroscopy
Claus et al.
RadioGraphics 2004;24:S167-S180.
ABSTRACT | FULL TEXT  

Age-Related Disparities in Cancer Screening: Analysis of 2001 Behavioral Risk Factor Surveillance System Data
Jerant et al.
Ann Fam Med 2004;2:481-487.
ABSTRACT | FULL TEXT  

Colorectal Cancer Screening Knowledge, Attitudes, and Beliefs Among Veterans: Does Literacy Make a Difference?
Dolan et al.
JCO 2004;22:2617-2622.
ABSTRACT | FULL TEXT  

Fractures, Osteoporosis, and the Endocrinologist
Field
Arch Intern Med 2003;163:2796-2796.
FULL TEXT  

Minerva
BMJ 2003;327:E235-235.
FULL TEXT  

Annual Report to the Nation on the Status of Cancer, 1975-2000, Featuring the Uses of Surveillance Data for Cancer Prevention and Control
Weir et al.
JNCI J Natl Cancer Inst 2003;95:1276-1299.
ABSTRACT | FULL TEXT  

Prostate Cancer Screening Rates Exceed Colorectal Cancer Screening Rates
JWatch Gastroenterology 2003;2003:1-1.
FULL TEXT  

Men More Likely to Be Screened for Prostate Cancer Than for Colorectal Cancer
JWatch General 2003;2003:1-1.
FULL TEXT  

In brief
BMJ 2003;326:728-728.
FULL TEXT  

Minerva
BMJ 2003;326:720-720.
FULL TEXT